Clinical Trials · NCT07859163

Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain

Not Yet RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Not Yet Recruiting
Sponsor
General Committee of Teaching Hospitals and Institutes, Egypt
Enrollment
100
Start date
Oct 2026
Locations
1 site, Egypt
Primary endpoint
Percentage total weight loss
View Semaglutide compound reference